Cala Health closed a $50 million funding round. The Silicon Valley-based company sells an FDA-cleared wearable device that temporarily relieves hand tremors in people with essential tremor and Parkinson’s disease.
Cala Health recently launched its kIQ system — which it calls the first noninvasive wearable device cleared by the FDA to temporarily relieve tremors in people with essential tremor and Parkinson’s disease.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Cala Health recently published a post-market study showing that its wrist-based wearable to treat essential tremor effectively reduced patients' tremor power with no loss of effect over time. Most patients involved in the study reported improvement in daily activities, such as eating, drinking, texting and writing.
Renee Ryan hopes to see the vision of Cala Health's founder - who believed that Cala Health's wearable neurostimulation device can be one of the treatment modalities for chronic diseases like essential tremor - translated to reality.
Cala Health, a company with a wearable device for essential tremor, recently raised $77 million in funding. It plans to expand to more indications and seek more coverage of its device with the funds.
The startup, which has a cleared device to reduce tremors using electrical stimulation, recently shared the results of a post-market analysis showing device use and efficacy.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
In the runup to the MedCity INVEST conference April 21-22 in Chicago focusing on healthcare innovation, leaders from Luma Health to the Penn Center for Community Health Workers shared their insights on patient engagement.
The Burlingame, California-based startup bills itself as a bioelectric medicine company that is using electric signals to stimulate the nervous system as a pathway to treat chronic disease.
A panel at the MedCity INVEST conference in Chicago on April 23 will convene leaders from medtech companies, health systems and investment firms to share their perspectives on how healthcare stakeholders are adapting to effectively utilize and enable new data streams.
Cala Health, a Stanford spinout operating in stealth, has raised $18 million - seemingly to advance its wearable technology that treats hand and wrist tremors.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.